Buscar
01/04/2026
Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain
Araujo-Castro, M, Garcia-Centeno, R, Fernández, LG, Soto-Moreno, A, Camara, R, García, MDO, Echarri, AI, Gracia, P, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Guerrero-Perez, F, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Tenorio-Jimenéz, C, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Paja, M, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Hanzu, FA. Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2026; 49(4)DOI:10.1007/s40618-025-02769-0. PMID:41335191. IF:3.500(Q2/4D).
01/04/2026
Question: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Question: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf149. PMID:41883263. IF:4.600(Q1/2D).
01/04/2026
Answer: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Answer: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf150. PMID:41922903. IF:4.600(Q1/2D).
01/04/2026
Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry
Ballesteros, MA, Barge-Caballero, G, Herrador, L, Gomez-Bueno, M, Caravaca, P, de Antonio-Ferrer, M, Vilella, RL, Rivas, S, Manrique-Antón, R, Palacios-Castelló, C, Cobo-Belaustegui, M, Crespin-Crespin, M, de la Fuente-galán, L, de Sanmamed-Girón, MF, Ortiz-Bautista, C, Diaz-Molina, B, Blasco-Peiró, T, Barge-Caballero, E, Crespo-LeiroServicio, MG. Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes
Cosio, MG, Severo, A, Gonzalez-Vilchez, F, Lopez-Vilella, R, Bueno, MG, Couto-Mallon, D, Blazquez, Z, Caravaca, P, Alarcos, H, Molina, BD, Romero, EG, Perez, SM, Marquez, MS, Bravo, IG, Tobar, J, Peiro, MB, Muñiz, J, Delgado, J. Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Wypych-Zych, A, Jean-Baptiste, G, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Ibero, J, Topciu, T, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice
Olveira, A, Crespo, J, Ibañez-Samaniego, L, Gallego-Durán, R, Calleja, JL, Aller, R, Soria, A, Gómez-Camarero, J, Martín-Mateos, R, Benlloch, S, Pericàs, JM, Morillas, RM, Bernal-Monterde, V, Diago, M, Turnes, J, Poca, M, Lo Iacono, O, Maya-Miles, D, Escudero, D, Andrade, RJ, Rosales, JM, Jorquera, F, Fernández-Rodriguez, C, Hernández-Guerra, M, Romero-Gómez, M, Ampuero, J. Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice. Clinical Gastroenterology and Hepatology. 2026; 24(4)DOI:10.1016/j.cgh.2025.08.023. PMID:40907848. IF:12.000(Q1/1D).